Annual Total Assets
$3.26 B
+$136.21 M+4.35%
December 31, 2023
Summary
- As of February 22, 2025, SRPT annual total assets is $3.26 billion, with the most recent change of +$136.21 million (+4.35%) on December 31, 2023.
- During the last 3 years, SRPT annual total assets has risen by +$279.86 million (+9.38%).
- SRPT annual total assets is now at all-time high.
Performance
SRPT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$3.60 B
+$175.68 M+5.13%
September 30, 2024
Summary
- As of February 22, 2025, SRPT quarterly total assets is $3.60 billion, with the most recent change of +$175.68 million (+5.13%) on September 30, 2024.
- Over the past year, SRPT quarterly total assets has increased by +$335.36 million (+10.27%).
- SRPT quarterly total assets is now at all-time high.
Performance
SRPT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
SRPT Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.3% | +10.3% |
| 3 y3 years | +9.4% | +14.1% |
| 5 y5 years | +98.8% | +14.1% |
SRPT Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4.3% | at high | +20.1% |
| 5 y | 5-year | at high | +79.1% | at high | +97.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Sarepta Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.60 B(+5.1%) |
| Jun 2024 | - | $3.42 B(+6.2%) |
| Mar 2024 | - | $3.22 B(-1.2%) |
| Dec 2023 | $3.26 B(+4.4%) | $3.26 B(+5.0%) |
| Sep 2023 | - | $3.11 B(-0.5%) |
| Jun 2023 | - | $3.13 B(+2.2%) |
| Mar 2023 | - | $3.06 B(-2.2%) |
| Dec 2022 | $3.13 B(-0.6%) | $3.13 B(-0.9%) |
| Sep 2022 | - | $3.16 B(+5.3%) |
| Jun 2022 | - | $3.00 B(-1.9%) |
| Mar 2022 | - | $3.06 B(-2.9%) |
| Dec 2021 | $3.15 B(+5.5%) | $3.15 B(+18.2%) |
| Sep 2021 | - | $2.66 B(-3.5%) |
| Jun 2021 | - | $2.76 B(-0.2%) |
| Mar 2021 | - | $2.77 B(-7.4%) |
| Dec 2020 | $2.98 B(+63.7%) | $2.98 B(+7.3%) |
| Sep 2020 | - | $2.78 B(-3.6%) |
| Jun 2020 | - | $2.88 B(-2.2%) |
| Mar 2020 | - | $2.95 B(+61.7%) |
| Dec 2019 | $1.82 B(+11.0%) | $1.82 B(+7.1%) |
| Sep 2019 | - | $1.70 B(-2.6%) |
| Jun 2019 | - | $1.75 B(-11.0%) |
| Mar 2019 | - | $1.96 B(+19.6%) |
| Dec 2018 | $1.64 B(+25.5%) | $1.64 B(+38.8%) |
| Sep 2018 | - | $1.18 B(-5.2%) |
| Jun 2018 | - | $1.25 B(-4.1%) |
| Mar 2018 | - | $1.30 B(-0.6%) |
| Dec 2017 | $1.31 B(+208.4%) | $1.31 B(+63.4%) |
| Sep 2017 | - | $800.28 M(+77.8%) |
| Jun 2017 | - | $450.14 M(-12.0%) |
| Mar 2017 | - | $511.53 M(+20.6%) |
| Dec 2016 | $424.10 M(+54.9%) | $424.10 M(-13.0%) |
| Sep 2016 | - | $487.31 M(+138.8%) |
| Jun 2016 | - | $204.07 M(-4.4%) |
| Mar 2016 | - | $213.36 M(-22.1%) |
| Dec 2015 | $273.78 M(-7.2%) | $273.78 M(+48.2%) |
| Sep 2015 | - | $184.75 M(-20.3%) |
| Jun 2015 | - | $231.71 M(-4.5%) |
| Mar 2015 | - | $242.71 M(-17.7%) |
| Dec 2014 | $295.03 M(+1.2%) | $295.03 M(-7.5%) |
| Sep 2014 | - | $319.06 M(-5.4%) |
| Jun 2014 | - | $337.31 M(+22.5%) |
| Mar 2014 | - | $275.39 M(-5.5%) |
| Dec 2013 | $291.57 M(+42.2%) | $291.57 M(-4.2%) |
| Sep 2013 | - | $304.48 M(+65.8%) |
| Jun 2013 | - | $183.63 M(-5.0%) |
| Mar 2013 | - | $193.34 M(-5.7%) |
| Dec 2012 | $204.99 M(+277.0%) | $204.99 M(+286.2%) |
| Sep 2012 | - | $53.08 M(+26.1%) |
| Jun 2012 | - | $42.10 M(-9.7%) |
| Mar 2012 | - | $46.65 M(-14.2%) |
| Dec 2011 | $54.37 M(+18.3%) | $54.37 M(-11.0%) |
| Sep 2011 | - | $61.08 M(-18.5%) |
| Jun 2011 | - | $74.93 M(+59.3%) |
| Mar 2011 | - | $47.03 M(+2.3%) |
| Dec 2010 | $45.98 M | $45.98 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $50.86 M(+4.5%) |
| Jun 2010 | - | $48.67 M(-7.9%) |
| Mar 2010 | - | $52.83 M(-12.0%) |
| Dec 2009 | $60.03 M(+135.1%) | $60.03 M(-7.8%) |
| Sep 2009 | - | $65.12 M(+99.7%) |
| Jun 2009 | - | $32.62 M(-11.9%) |
| Mar 2009 | - | $37.02 M(+45.0%) |
| Dec 2008 | $25.54 M(-33.9%) | $25.54 M(-13.5%) |
| Sep 2008 | - | $29.51 M(-9.4%) |
| Jun 2008 | - | $32.58 M(-8.2%) |
| Mar 2008 | - | $35.48 M(-8.2%) |
| Dec 2007 | $38.64 M(-5.4%) | $38.64 M(+43.8%) |
| Sep 2007 | - | $26.86 M(-13.9%) |
| Jun 2007 | - | $31.21 M(-11.6%) |
| Mar 2007 | - | $35.31 M(-13.6%) |
| Dec 2006 | $40.86 M(-27.6%) | $40.86 M(-12.2%) |
| Sep 2006 | - | $46.54 M(-11.2%) |
| Jun 2006 | - | $52.38 M(-9.9%) |
| Mar 2006 | - | $58.12 M(+3.0%) |
| Dec 2005 | $56.41 M(+97.8%) | $56.41 M(+42.7%) |
| Sep 2005 | - | $39.52 M(-2.5%) |
| Jun 2005 | - | $40.54 M(-11.3%) |
| Mar 2005 | - | $45.70 M(+60.2%) |
| Dec 2004 | $28.52 M(-39.5%) | $28.52 M(-11.9%) |
| Sep 2004 | - | $32.37 M(-15.1%) |
| Jun 2004 | - | $38.14 M(-16.7%) |
| Mar 2004 | - | $45.80 M(-2.8%) |
| Dec 2003 | $47.15 M(+64.8%) | $47.15 M(+27.0%) |
| Sep 2003 | - | $37.12 M(-6.3%) |
| Jun 2003 | - | $39.62 M(+85.7%) |
| Mar 2003 | - | $21.33 M(-25.4%) |
| Dec 2002 | $28.60 M(-15.4%) | $28.60 M(-7.0%) |
| Sep 2002 | - | $30.74 M(-18.1%) |
| Jun 2002 | - | $37.53 M(-16.8%) |
| Mar 2002 | - | $45.14 M(+33.5%) |
| Dec 2001 | $33.82 M(-3.6%) | $33.82 M(+2.0%) |
| Sep 2001 | - | $33.14 M(-15.8%) |
| Jun 2001 | - | $39.37 M(+29.3%) |
| Mar 2001 | - | $30.46 M(-13.2%) |
| Dec 2000 | $35.09 M(+172.0%) | $35.09 M(-12.3%) |
| Sep 2000 | - | $40.01 M(+222.0%) |
| Jun 2000 | - | $12.43 M(-21.3%) |
| Mar 2000 | - | $15.79 M(+22.4%) |
| Dec 1999 | $12.90 M(+26.5%) | $12.90 M(+239.5%) |
| Sep 1999 | - | $3.80 M(-33.3%) |
| Jun 1999 | - | $5.70 M(-28.7%) |
| Mar 1999 | - | $8.00 M(-21.6%) |
| Dec 1998 | $10.20 M(-45.7%) | $10.20 M(-19.0%) |
| Sep 1998 | - | $12.60 M(-20.3%) |
| Jun 1998 | - | $15.80 M(-9.7%) |
| Mar 1998 | - | $17.50 M(-6.9%) |
| Dec 1997 | $18.80 M(+347.6%) | $18.80 M(-3.1%) |
| Sep 1997 | - | $19.40 M(+4.9%) |
| Jun 1997 | - | $18.50 M(+400.0%) |
| Mar 1997 | - | $3.70 M |
| Dec 1996 | $4.20 M | - |
FAQ
- What is Sarepta Therapeutics annual total assets?
- What is the all time high annual total assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total assets year-on-year change?
- What is Sarepta Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total assets year-on-year change?
What is Sarepta Therapeutics annual total assets?
The current annual total assets of SRPT is $3.26 B
What is the all time high annual total assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total assets is $3.26 B
What is Sarepta Therapeutics annual total assets year-on-year change?
Over the past year, SRPT annual total assets has changed by +$136.21 M (+4.35%)
What is Sarepta Therapeutics quarterly total assets?
The current quarterly total assets of SRPT is $3.60 B
What is the all time high quarterly total assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total assets is $3.60 B
What is Sarepta Therapeutics quarterly total assets year-on-year change?
Over the past year, SRPT quarterly total assets has changed by +$335.36 M (+10.27%)